MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,618,000 | +74.9% | 60,000 | +33.3% | 1.80% | +96.3% |
| Q1 2016 | $2,069,000 | -35.9% | 45,000 | +80.0% | 0.92% | -16.6% |
| Q1 2015 | $3,227,000 | +8.4% | 25,000 | -16.4% | 1.10% | -9.0% |
| Q4 2014 | $2,978,000 | +20.5% | 29,900 | +19.6% | 1.21% | +7.3% |
| Q3 2014 | $2,472,000 | +92.1% | 25,000 | +25.0% | 1.12% | +40.0% |
| Q1 2014 | $1,287,000 | -59.7% | 20,000 | -60.0% | 0.80% | -64.6% |
| Q4 2013 | $3,191,000 | – | 50,000 | – | 2.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |